Icon's balance sheet is sound, with its revenue cyclicality and operating leverage each possessing a medium rating. Icon has historically maintained a fairly conservative balance sheet, and it ended ...

The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

Shipping investor Oaktree bought into OSM Maritime Group in 2018. The group merged with Thome Ship Management in Singapore to ...

Stifel raised the firm’s price target on Cheniere Energy (LNG) to $255 from $237 and keeps a Buy rating on the shares after Cheniere reported ...

Chinese video streaming platform iQIYI on Thursday raised $350 million in an upsized five-year convertible bond, a day after ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

A bipartisan challenge to the SEC's exclusion of staking from ETPs is an essential step to maintaining America’s ...

The Trump administration is planning to fire members of the independent government board that oversees the US Postal Service, a move that could serve as a step toward privatizing the service, ...

(Reuters) - Franklin Templeton filed for an exchange-traded fund on Friday that will track the spot price of Solana, ...

Visit the post for more.

U.S. President Donald Trump and billionaire Elon Musk, one of his closest advisers, have mounted a sweeping campaign to slash ...